These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

858 related items for PubMed ID: 26232154

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Microglia depletion rapidly and reversibly alters amyloid pathology by modification of plaque compaction and morphologies.
    Casali BT, MacPherson KP, Reed-Geaghan EG, Landreth GE.
    Neurobiol Dis; 2020 Aug; 142():104956. PubMed ID: 32479996
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer's-like pathology.
    Olmos-Alonso A, Schetters ST, Sri S, Askew K, Mancuso R, Vargas-Caballero M, Holscher C, Perry VH, Gomez-Nicola D.
    Brain; 2016 Mar; 139(Pt 3):891-907. PubMed ID: 26747862
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Microglial response to Alzheimer's disease is differentially modulated by voluntary wheel running and enriched environments.
    Rodríguez JJ, Noristani HN, Verkhratsky A.
    Brain Struct Funct; 2015 Mar; 220(2):941-53. PubMed ID: 24374506
    [Abstract] [Full Text] [Related]

  • 8. CSF1R inhibition rescues tau pathology and neurodegeneration in an A/T/N model with combined AD pathologies, while preserving plaque associated microglia.
    Lodder C, Scheyltjens I, Stancu IC, Botella Lucena P, Gutiérrez de Ravé M, Vanherle S, Vanmierlo T, Cremers N, Vanrusselt H, Brône B, Hanseeuw B, Octave JN, Bottelbergs A, Movahedi K, Dewachter I.
    Acta Neuropathol Commun; 2021 Jun 08; 9(1):108. PubMed ID: 34103079
    [Abstract] [Full Text] [Related]

  • 9. Concentration-dependent effects of CSF1R inhibitors on oligodendrocyte progenitor cells ex vivo and in vivo.
    Liu Y, Given KS, Dickson EL, Owens GP, Macklin WB, Bennett JL.
    Exp Neurol; 2019 Aug 08; 318():32-41. PubMed ID: 31029597
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Selective targeting and modulation of plaque associated microglia via systemic hydroxyl dendrimer administration in an Alzheimer's disease mouse model.
    Henningfield CM, Soni N, Lee RW, Sharma R, Cleland JL, Green KN.
    Alzheimers Res Ther; 2024 May 06; 16(1):101. PubMed ID: 38711159
    [Abstract] [Full Text] [Related]

  • 13. Increased densities of resting and activated microglia in the dentate gyrus follow senile plaque formation in the CA1 subfield of the hippocampus in the triple transgenic model of Alzheimer's disease.
    Rodríguez JJ, Noristani HN, Hilditch T, Olabarria M, Yeh CY, Witton J, Verkhratsky A.
    Neurosci Lett; 2013 Sep 27; 552():129-34. PubMed ID: 23827221
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Microglia facilitate loss of perineuronal nets in the Alzheimer's disease brain.
    Crapser JD, Spangenberg EE, Barahona RA, Arreola MA, Hohsfield LA, Green KN.
    EBioMedicine; 2020 Aug 27; 58():102919. PubMed ID: 32745992
    [Abstract] [Full Text] [Related]

  • 16. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
    Shin MK, Kim HG, Baek SH, Jung WR, Park DI, Park JS, Jo DG, Kim KL.
    Neurobiol Aging; 2014 May 27; 35(5):990-1001. PubMed ID: 24268884
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Modulation of hippocampal protein expression by a brain penetrant biologic TNF-α inhibitor in the 3xTg Alzheimer's disease mice.
    Jagadeesan N, Roules GC, Chandrashekar DV, Yang J, Kolluru S, Sumbria RK.
    J Transl Med; 2024 Mar 18; 22(1):291. PubMed ID: 38500108
    [Abstract] [Full Text] [Related]

  • 20. Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease.
    Boissonneault V, Filali M, Lessard M, Relton J, Wong G, Rivest S.
    Brain; 2009 Apr 18; 132(Pt 4):1078-92. PubMed ID: 19151372
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.